154 related articles for article (PubMed ID: 16796774)
1. Meeting highlights from: 47th Annual Meeting of the American Society of Hematology December 2005, Atlanta, GA.
Clin Lymphoma Myeloma; 2006 May; 6(6):448-54. PubMed ID: 16796774
[No Abstract] [Full Text] [Related]
2. 6th European Hematology Association Meeting. Frankfurt, Germany. June 21-24, 2001.
Maung K; D'Orazio AI
Clin Lymphoma; 2001 Sep; 2(2):74-9. PubMed ID: 11712544
[No Abstract] [Full Text] [Related]
3. Rituximab-CHOP or 2-weekly CHOP + G-CSF in aggressive lymphoma of the elderly?
Bernardi D; Giacalone A; Spina M; Tirelli U
Ann Oncol; 2004 Aug; 15(8):1298. PubMed ID: 15277275
[No Abstract] [Full Text] [Related]
4. 45th annual meeting of the American Society of Hematology. December 6-9, 2003, San Diego, California.
Clin Lymphoma; 2003 Dec; 4(3):141-8. PubMed ID: 14715094
[No Abstract] [Full Text] [Related]
5. Select interviews from the 2011 San Antonio Breast Cancer Symposium (SABCS) and American Society of Hematology (ASH) Annual Meeting.
Osborne CK; Evens A
Oncology (Williston Park); 2011 Dec; 25(14):1422-4, 1426. PubMed ID: 22329194
[No Abstract] [Full Text] [Related]
6. The rapidly expanding role of rituximab in the treatment of aggressive B-cell lymphoma.
Cooper D
Cancer J; 2002; 8(5):364-6. PubMed ID: 12416891
[No Abstract] [Full Text] [Related]
7. Rituximab in the treatment of diffuse large B-cell lymphomas.
Coiffier B
Semin Oncol; 2002 Feb; 29(1 Suppl 2):30-5. PubMed ID: 11842386
[TBL] [Abstract][Full Text] [Related]
8. [Rituximab, a chimeric mouse-human anti-CD20 monoclonal antibody].
Tobinai K
Nihon Rinsho; 2002 Mar; 60(3):468-72. PubMed ID: 11904960
[TBL] [Abstract][Full Text] [Related]
9. [Recent progress in rituximab therapy and its resistance--how do we overcome?].
Hatake K; Yokoyama M; Terui Y
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1177-82. PubMed ID: 17687198
[TBL] [Abstract][Full Text] [Related]
10. The treatment of lymphoma complicating autoimmune disease: two birds with one stone?
Mikuls TR
Ann Oncol; 2007 Apr; 18(4):615-8. PubMed ID: 17355949
[No Abstract] [Full Text] [Related]
11. Developing new monoclonal antibodies for aggressive lymphoma: a challenging road in the rituximab era.
Friedberg JW
Clin Cancer Res; 2004 Aug; 10(16):5297-8. PubMed ID: 15328164
[No Abstract] [Full Text] [Related]
12. Aggressive lymphoma: improving treatment outcome with rituximab.
Coiffier B; Pfreundschuh M; Stahel R; Vose J; Zinzani PL
Anticancer Drugs; 2002 Nov; 13 Suppl 2():S43-50. PubMed ID: 12710590
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies in elderly patients with aggressive histology lymphoma.
Kouroukis CT; Meyer RM
Ann Hematol; 2001; 80 Suppl 3():B86-8. PubMed ID: 11757717
[No Abstract] [Full Text] [Related]
14. Intensive chemotherapy with rituximab is safe and effective in AIDS non-Hodgkin's lymphoma.
Rey J; Charbonnier A; Schiano de Colella JM; Stoppa AM; Poizot-Martin I; Gastaut JA; Costello RT
AIDS; 2003 Sep; 17(13):2006-7. PubMed ID: 12960844
[No Abstract] [Full Text] [Related]
15. Worsening of psoriasis with rituximab therapy.
Olivieri I; D'Angelo S; Leccese P; Vertone D; Olivieri A
Clin Exp Rheumatol; 2010; 28(6):926. PubMed ID: 21205468
[No Abstract] [Full Text] [Related]
16. Primary effusion lymphoma (PEL) revisited: a hematologist's perspective.
Desai S; Freeman NJ
Clin Adv Hematol Oncol; 2004 Jan; 2(1):60-1. PubMed ID: 16163162
[No Abstract] [Full Text] [Related]
17. 49th Annual Meeting of the American Society of Hematology, Atlanta, GA; December 8-11, 2007.
Clin Lymphoma Myeloma; 2008 Apr; 8(2):77-86. PubMed ID: 18564453
[No Abstract] [Full Text] [Related]
18. Intravascular lymphoma presenting with cauda equina syndrome: treated with CHOP and rituxan.
Davis TS
Leuk Lymphoma; 2003 May; 44(5):887-8. PubMed ID: 12802932
[No Abstract] [Full Text] [Related]
19. Breast lymphoma.
Avilés A
Ann Oncol; 2008 Jul; 19(7):1360. PubMed ID: 18579558
[No Abstract] [Full Text] [Related]
20. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.
Mangel J; Buckstein R; Imrie K; Spaner D; Crump M; Tompkins K; Reis M; Perez-Ordonez B; Deodhare S; Romans R; Pennell N; Robinson JB; Hewitt K; Richardson P; Lima A; Pavlin P; Berinstein NL
Semin Oncol; 2002 Feb; 29(1 Suppl 2):56-69. PubMed ID: 11842390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
